Alseres Pharmaceuticals - Treating Neurodegenerative Disorders & CNS Disorders

2024-06-19

Alseres Pharmaceuticals develops diagnostic and therapeutic products such as ALTROPANE, INOSINE, and DAT blockers for neurodegenerative disorders, CNS disorders, movement disorders, and spinal cord injuries.

Researches and develops novel therapeutic and diagnostic products to treat chronic debilitating diseases such as cancer, central nervous system disorders and autoimmune diseases. Based in Massachusetts. (Nasdaq: BLSI).

Boston Life Sciences, Inc.